BOSTON, MA / May 13, 2025 / Medisafe, the leading digital health platform for medication engagement, today announced a collaboration with SpringWorks Therapeutics to launch the GOMEKLI™ (mirdametinib) Digital Companion by Medisafe—an innovative, behaviorally driven platform designed to support GOMEKLI patients living with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas (NF1-PN).
Read more here.
![[Kenna Security in The Fintech Times] Kenna Security: FinServ’s Newfound Appreciation for Cybersecurity Teams](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
